Total Payments
$726.09
2024 Payments
$89.56
Companies
9
Transactions
20
Medicare Patients
1,673
Medicare Billing
$196,860
Payment Breakdown by Category
Food & Beverage$678.93 (93.5%)
Education$47.16 (6.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $678.93 | 17 | 93.5% |
| Education | $47.16 | 3 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $160.81 | 4 | $0 (2022) |
| PFIZER INC. | $124.99 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $96.81 | 7 | $0 (2022) |
| Pharmacosmos Therapeutics Inc. | $89.56 | 1 | $0 (2024) |
| Gilead Sciences Inc | $84.86 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $63.90 | 1 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $47.16 | 3 | $0 (2018) |
| Mallinckrodt Hospital Products Inc. | $41.28 | 1 | $0 (2023) |
| Medtronic, Inc. | $16.72 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $89.56 | 1 | Pharmacosmos Therapeutics Inc. ($89.56) |
| 2023 | $41.28 | 1 | Mallinckrodt Hospital Products Inc. ($41.28) |
| 2022 | $132.94 | 8 | ABBVIE INC. ($60.81) |
| 2021 | $41.40 | 3 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($41.40) |
| 2019 | $124.99 | 1 | PFIZER INC. ($124.99) |
| 2018 | $111.06 | 4 | Merck Sharp & Dohme Corporation ($63.90) |
| 2017 | $184.86 | 2 | AbbVie, Inc. ($100.00) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $89.56 | General |
| Category: HEMATOLOGY | ||||||
| 06/07/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $41.28 | General |
| Category: CRITICAL CARE | ||||||
| 12/21/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Gastroenterology | ||||||
| 11/07/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: VIROLOGY | ||||||
| 08/12/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Gastroenterology | ||||||
| 08/03/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: VIROLOGY | ||||||
| 06/15/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Gastroenterology | ||||||
| 06/08/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: VIROLOGY | ||||||
| 05/18/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Gastroenterology | ||||||
| 02/09/2022 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/01/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Gastroenterology | ||||||
| 11/03/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Gastroenterology | ||||||
| 10/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Gastroenterology | ||||||
| 03/05/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/14/2018 | Merck Sharp & Dohme Corporation | RENFLEXIS (Biological) | Food and Beverage | In-kind items and services | $63.90 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2018 | Alexion Pharmaceuticals, Inc. | Kanuma (Drug) | Education | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
| 05/30/2018 | Alexion Pharmaceuticals, Inc. | Kanuma (Drug) | Education | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
| 01/18/2018 | Alexion Pharmaceuticals, Inc. | Kanuma (Drug) | Education | In-kind items and services | $18.16 | General |
| Category: Immunology | ||||||
| 10/11/2017 | AbbVie, Inc. | Viekira (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Virology | ||||||
| 09/27/2017 | Gilead Sciences Inc | Epclusa (Drug) | Food and Beverage | In-kind items and services | $84.86 | General |
| Category: HCV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 704 | 917 | $489,443 | $88,148 |
| 2022 | 12 | 330 | 398 | $298,077 | $40,644 |
| 2021 | 9 | 277 | 313 | $236,730 | $34,707 |
| 2020 | 12 | 362 | 385 | $348,210 | $33,361 |
Total Patients
1,673
Total Services
2,013
Medicare Billing
$196,860
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 139 | 257 | $74,036 | $25,322 | 34.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 155 | 161 | $65,029 | $16,875 | 25.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 162 | 248 | $60,533 | $15,862 | 26.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 94 | 95 | $70,470 | $13,400 | 19.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 23 | 23 | $40,129 | $4,721 | 11.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 55 | 56 | $78,545 | $4,305 | 5.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 25 | 25 | $26,878 | $2,384 | 8.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $17,747 | $1,932 | 10.9% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 12 | $17,442 | $1,727 | 9.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 26 | 26 | $38,634 | $1,621 | 4.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 57 | 104 | $36,857 | $8,819 | 23.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 37 | $26,885 | $6,025 | 22.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $24,640 | $4,889 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 41 | $16,933 | $4,264 | 25.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 33 | 33 | $17,798 | $3,794 | 21.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 19 | 19 | $45,353 | $3,590 | 7.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $12,320 | $2,244 | 18.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 28 | 29 | $50,710 | $1,992 | 3.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 22 | 22 | $40,788 | $1,703 | 4.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 18 | $4,950 | $1,321 | 26.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $16,978 | $1,148 | 6.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 14 | $3,865 | $855.84 | 22.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 46 | 47 | $26,726 | $7,864 | 29.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 58 | 85 | $27,143 | $7,358 | 27.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 20 | 20 | $47,740 | $4,230 | 8.9% |
About Dr. Waseem Butt, MD
Dr. Waseem Butt, MD is a Internal Medicine healthcare provider based in Newtown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346304847.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Waseem Butt, MD has received a total of $726.09 in payments from pharmaceutical and medical device companies, with $89.56 received in 2024. These payments were reported across 20 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($678.93).
As a Medicare-enrolled provider, Butt has provided services to 1,673 Medicare beneficiaries, totaling 2,013 services with total Medicare billing of $196,860. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Gastroenterology
- Location Newtown, PA
- Active Since 12/20/2006
- Last Updated 08/14/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346304847
Products in Payments
- XELJANZ (Drug) $124.99
- Viekira (Drug) $100.00
- MONOFERRIC (Drug) $89.56
- Epclusa (Drug) $84.86
- XIFAXAN (Drug) $69.02
- RENFLEXIS (Biological) $63.90
- MAVYRET (Drug) $60.81
- Kanuma (Drug) $47.16
- TERLIVAZ (Drug) $41.28
- TRULANCE (Drug) $27.79
- INTERSTIM (Device) $16.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newtown
Jennifer Holloway, M.d, M.D
Internal Medicine — Payments: $23,629
Internal Medicine $23,629
Peter Licht, M.d, M.D
Internal Medicine — Payments: $16,931
Internal Medicine $16,931
Anil Patel, M.d, M.D
Internal Medicine — Payments: $12,019
Internal Medicine $12,019
Jeffrey Friedman, Md, MD
Internal Medicine — Payments: $4,912
Internal Medicine $4,912
Giacomo Mangiaracina, Md, MD
Internal Medicine — Payments: $3,284
Internal Medicine $3,284
Dr. Flora Parvin, Md, MD
Internal Medicine — Payments: $414.22
Internal Medicine $414.22